Yahoo Finance - WJSAM Finance Hub

Yahoo Finance

Mizuho Lifts Coinbase (COIN) Price Target, Keeps Neutral Rating

Mizuho Lifts Coinbase (COIN) Price Target, Keeps N...

3 months ago 51

Needham Keeps Buy Rating on Carvana (CVNA) After Q3 Results

Needham Keeps Buy Rating on Carvana (CVNA) After Q...

3 months ago 47

Analysts Raise Price Targets on Expand Energy (EXE) After Q3 Results

Analysts Raise Price Targets on Expand Energy (EXE...

3 months ago 51

Analysts Stay Bullish on Micron Technology (MU)

Analysts Stay Bullish on Micron Technology (MU)

3 months ago 61

Scotiabank Keeps Sector Perform Rating on EQT After Q3 Results

Scotiabank Keeps Sector Perform Rating on EQT Afte...

3 months ago 44

Piper Sandler Raises AppLovin (APP) Price Target, Keeps Overweight Rating

Piper Sandler Raises AppLovin (APP) Price Target, ...

3 months ago 45

TD Cowen Maintains Buy on Eli Lilly (LLY) After Government Deal

TD Cowen Maintains Buy on Eli Lilly (LLY) After Go...

3 months ago 50

Taiwan Semiconductor Manufacturing Company (TSM) Board Approves Major Investment

Taiwan Semiconductor Manufacturing Company (TSM) B...

3 months ago 46

Taiwan Semiconductor Manufacturing Company (TSM) Board Approves Major Investment

Taiwan Semiconductor Manufacturing Company (TSM) B...

3 months ago 50

Despite China Issues, Nvidia (NVDA) Sees Strong Demand for Blackwell Chips

Despite China Issues, Nvidia (NVDA) Sees Strong De...

3 months ago 51

Despite China Issues, Nvidia (NVDA) Sees Strong Demand for Blackwell Chips

Despite China Issues, Nvidia (NVDA) Sees Strong De...

3 months ago 51

Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT

Stephens Initiates Twist Bioscience (TWST) With Ov...

3 months ago 45

Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT

Stephens Initiates Twist Bioscience (TWST) With Ov...

3 months ago 52

Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT

Evercore ISI Reiterates Buy Rating on Krystal Biot...

3 months ago 46

RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform

RBC Capital Lifts CRISPR Therapeutics (CRSP) Targe...

3 months ago 39

RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform

RBC Capital Lifts CRISPR Therapeutics (CRSP) Targe...

3 months ago 39

Evercore Downgrades Intellia (NTLA) Despite Strong ATTR Trial Data

Evercore Downgrades Intellia (NTLA) Despite Strong...

3 months ago 41

Evercore Downgrades Intellia (NTLA) Despite Strong ATTR Trial Data

Evercore Downgrades Intellia (NTLA) Despite Strong...

3 months ago 43